Follow Us: social media social media social media        

Pomalyst® (pomalidomide): New important advice- Hepatitis B Virus status to be established before initiating treatment with pomalidomide

Date: 19 January 2017

 

Description:

Reactivation of hepatitis B has been reported rarely following treatment with pomalidomide plus dexamethasone in patients previously infected with the hepatitis B virus (HBV). HBV status should be established before treatment with pomalidomide is initiated. A Direct Healthcare Professional Communication (DHPC) has been issued by Celgene Sdn. Bhd. in agreement with NPRA to highlight this information. Please refer to this DHPC for further information.

Like Us on Facebook

qrcode